Berkeley Lights, Inc.

Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

PhenomeX is enabling researchers to take advantage of each cell's full potential and launch the next phase of functional cell biology that will improve human health. We give researchers the most thorough understanding of how cells function and a detailed picture of each cell's behaviour.

Lockheed Martin

Virgin Galactic

Spotify

Thermo Fisher Scientific

TuSimple Holdings

Unity Software

After a steep selloff in emerging growth companies, opportunities abound. Here are seven Cathie Wood stocks worth considering right now.

7 Cathie Wood Stocks That Are Worth Buying Now

Cerner

Signature Bank

Silvergate Capital Corp

Waste Connections

Fund reveals investments in banks, biotech in 1st-quarter portfolio

The Top 5 Trades of Jerome Dodson's Parnassus Fund

EMERYVILLE, Calif., April 12, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be reporting financial results for the first quarter 2021 before market open on Tuesday, May 11, 2021. Company management will be webcasting a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.

Berkeley Lights to Report First Quarter 2021 Financial Results on May 11, 2021

Atara Biotherapeutics

Compugen

Cinedigm

Cardiff Oncology

Akerna Corp

Zedge

These seven stocks may be risky, but they also have the potential for big returns -- as all of them are stocks that could double by summer. The post 7 Stocks That Could Double by Summer appeared first on InvestorPlace.

7 Stocks That Could Double by Summer

EMERYVILLE, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Today, Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, announced the launch of Opto Assure, a series of assays that provides yield and product quality data at an earlier stage in cell line development. The first of the series enables direct detection of product aggregates, ensuring a faster ramp toward volume production by evaluating biotherapeutic protein quality sooner in the antibody therapeutic development process. With Opto Assure, customers can rapidly select clonal cell lines with favorable manufacturability profiles, leading to decreased scale-up costs and better downstream products.

Berkeley Lights Announces Opto™ Assure For Early Manufacturability Assessment of Antibody Therapeutics

EMERYVILLE, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating in the upcoming KeyBanc Life Sciences & MedTech Investor Forum.

Berkeley Lights to Participate in the KeyBanc Life Sciences & MedTech Investor Forum

Berkeley Lights, Inc. (BLI) CEO Eric Hobbs on Q4 2020 Results - Earnings Call Transcript

Berkeley Lights operates in a high growth and rapidly expanding area of biotech. The company looks to continue to build on its first mover advantage. The company is now trading below the price reached after the IPO in July as it is currently a victim of the carnage in growth stocks.

Berkeley Lights: The Arms Supplier To Emerging Biotech Now At A Reasonable Price

EMERYVILLE, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating in the upcoming Cowen 41st Annual Healthcare Conference.

Berkeley Lights to Participate in the Cowen 41st Annual Healthcare Conference

Berkeley Lights (BLI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Why Earnings Season Could Be Great for Berkeley Lights (BLI)

Kurt Wood appointed CFO; Industry Veterans Pete Leddy, as CHRO, and Mimi Healy, as CPO, join Berkeley Lights

Berkeley Lights Announces CFO Transition and C-Level Additions

EMERYVILLE, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the Opto™ Plasma B Discovery 4.0 workflow. Opto Plasma B Discovery 4.0 is the industry's premier antibody discovery workflow by advancing from B cells to lead molecules in just 1 week.

Berkeley Lights Launches Opto Plasma B Discovery 4.0 to Accelerate Therapeutic Antibody Discovery Against Difficult Targets

EMERYVILLE, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating in the upcoming 39th Annual J.P. Morgan Virtual Healthcare Conference.

Berkeley Lights to Participate in the 39th Annual J.P. Morgan Healthcare Conference

Berkeley Lights (BLI) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Berkeley Lights (BLI) in Focus: Stock Moves 6.3% Higher

EMERYVILLE, Calif., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc., a leader in Digital Cell Biology, today announced the pricing of its previously announced public offering of 3,000,000 shares of common stock to be sold by certain selling stockholders of Berkeley Lights at a public offering price of $86.00 per share. In addition, the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 450,000 shares of common stock. The offering is expected to close on or about November 23, 2020, subject to the satisfaction of customary closing conditions. The selling stockholders will receive all of the net proceeds from the offering. Berkeley Lights will not receive any proceeds from the offering.

Berkeley Lights Announces Pricing of Public Offering by Selling Stockholders

EMERYVILLE, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc., a leader in Digital Cell Biology, today announced the launch of a public offering of 3,000,000 shares of common stock to be sold by certain selling stockholders of Berkeley Lights. In addition, the selling stockholders are expected to grant the underwriters a 30-day option to purchase up to an additional 450,000 shares of common stock. The selling stockholders will receive all of the net proceeds from the offering. Berkeley Lights will not receive any proceeds from the offering.

Berkeley Lights Announces Launch of Public Offering by Selling Stockholders

Berkeley Lights, Inc. (BLI) CEO Eric Hobbs on Q3 2020 Results - Earnings Call Transcript

EMERYVILLE, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today reported financial results for the quarter ended September 30, 2020.

Berkeley Lights Reports Financial Results for Third Quarter of Fiscal Year 2020

EMERYVILLE, Calif., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be report financial results for the third quarter 2020 after market close on Thursday, November 12, 2020. Company management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Berkeley Lights Announces Webcast of Third Quarter Financial Results on November 12, 2020

Eric Hobbs discusses how Berkeley Lights is not just fighting COVID-19, but also accelerating the design-build-test cycle for all of synthetic biology.

Bioeconomy Powerhouse Berkeley Lights Nearly Triples Since IPO, Now Valued At $3.9B

MIAOLI, Taiwan and EMERYVILLE, Calif., Sept.  09, 2020  (GLOBE NEWSWIRE) -- Mycenax Biotech, Inc. (4726.TWO), a pioneer of biopharmaceutical development in Taiwan, today announced its adoption of the Berkeley Lights Platform for cell line development. Berkeley Lights, Inc., (Nasdaq: BLI), a leader in Digital Cell Biology, continues to see adoption of the system in Asia Pacific, as Mycenax becomes the first company in Taiwan to use the technology.

Berkeley Lights Makes Debut in Taiwan as Mycenax Acquires the BeaconⓇ Optofluidic System for Cell Line Development

EMERYVILLE, Calif., Sept.  01, 2020  (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare Conference.

Berkeley Lights to Participate in the Morgan Stanley 2020 Healthcare Conference

EMERYVILLE, Calif., Aug.  25, 2020  (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today reported financial results for the quarter ended June 30, 2020.

Berkeley Lights Reports Financial Results for Second Quarter of Fiscal Year 2020

EMERYVILLE, Calif., July  21, 2020  (GLOBE NEWSWIRE) -- Berkeley Lights, Inc., (Nasdaq: BLI) a leader in Digital Cell Biology, today announced the closing of its initial public offering of 9,315,000 shares of common stock, including the exercise in full by the underwriters of their option to purchase up to an additional 1,215,000 shares of common stock, at a public offering price of $22.00 per share. The gross proceeds from the offering were approximately $204.9 million, before deducting underwriting discounts, commissions and other offering expenses payable by Berkeley Lights. Shares of Berkeley Lights’ common stock began trading on the Nasdaq Global Select Market on July 17, 2020 under the ticker symbol “BLI”.  All shares in the offering were offered by Berkeley Lights.

Berkeley Lights Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Shares of Berkeley Lights Inc. BLI, +134.09% took flight Friday, as the cell biology company went public at a price that was more than double what the upsized initial public offering was priced.

News for Berkeley Lights, Inc. Stock (BLI)